Shares of Alliance Pharma plc (LON:APH) hit a new 52-week high during trading on Tuesday . The company traded as high as GBX 63 ($0.85) and last traded at GBX 61.50 ($0.83), with a volume of 458373 shares traded. The stock had previously closed at GBX 61.75 ($0.83).
A number of analysts have commented on the company. N+1 Singer restated a “not rated” rating on shares of Alliance Pharma in a research report on Wednesday, September 13th. FinnCap restated a “buy” rating and issued a GBX 58 ($0.78) price target on shares of Alliance Pharma in a research report on Thursday, September 14th. Investec assumed coverage on Alliance Pharma in a research report on Wednesday, September 13th. They issued a “buy” rating and a GBX 59 ($0.79) price target for the company. Finally, Numis Securities restated a “buy” rating and issued a GBX 60 ($0.81) price target on shares of Alliance Pharma in a research report on Wednesday, September 13th.
The business also recently declared a dividend, which will be paid on Thursday, January 11th. Shareholders of record on Thursday, December 21st will be given a GBX 0.44 ($0.01) dividend. This represents a yield of 0.84%. The ex-dividend date of this dividend is Thursday, December 21st.
Alliance Pharma Company Profile
Alliance Pharma plc is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in acquisition, marketing and distribution of pharmaceutical products. The Company operates in various business areas, such as Hydromol, secondary care, community and consumer products, established products and international.
What are top analysts saying about Alliance Pharma plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Alliance Pharma plc and related companies.